About Rajiv Gandhi Cancer Institute & Research Centre
Rajiv Gandhi Cancer Institute & Research Centre is today counted amongst Asia’s premier exclusive cancer centres, that offers the unique advantage of cutting edge technology, put to use by renowned super specialists. This potent combination of man and machine ensures world-class cancer care to not only patients from India, but also from the neighboring SAARC countries and others. We are fortunate to have taken care of over 1.95 Lakh patients since inception in 1996. The Institute has been accredited by NABH and NABL for its quality of services, and holds ISO 9001 and ISO 14001 certifications.
The Institute offers super specialized tertiary care services in Medical, Surgical and Radiation Oncology, streamlined into dedicated Site-Specific teams. Super Specialists at RGCIRC practice an organ specific multi-disciplinary approach to cancer diagnosis and treatment, with the Tumor Board acting as a second opinion clinic for cases that are more critical than others.
Spread over nearly 2 lakh square feet area, with a current capacity of 300 beds, RGCIRC is one of the largest tertiary cancer care centres in the continent. The Institute’s outpatient services are spread on three floors with 57 consultation rooms, and well designed Radiation Therapy areas. RGCIRC has 9 state-of-the-art well equipped modular Operation Theatres with three stage air filtration and gas scavenging systems, and 2 Minor Operation Theatres for Day Care Surgeries. The Institute has 27 bedded Surgical ICU and an 11 bedded Medical ICU. RGCIRC has a dedicated Leukemia ward, and a separate Thyroid Ward. The Institute also boasts of an independent Bone Marrow Transplant unit that is credited with pioneering unrelated donor transplants, MUD transplants, and stem cell transplants.
RGCIRC is committed to bringing the benefits of cutting edge technology to its patients. The Institute offers best in class techniques such as whole-body robotic surgery, Intra-Operative Brachytherapy, True Beam (the next generation Image Guided Radiation Therapy), PET – MRI fusion, High Frequency Ultrasound, Tomosynthesis (first-of-its-kind revolutionary 3D mammography machine), Nucleic Acid Testing (for safest possible blood), and advanced diagnostic & imaging techniques, including PET CT, Circulating Tumor Cell testing, and Next Generation Sequencing. RGCIRC has executed strategic alliances with internationally renowned institutes such as Thomas Jefferson University. This has catapulted RGCIRC into a global league of select hospitals that are pioneers in new approaches to treating cancer.
RGCIRC has been ranked amongst 10 Best Oncology Hospitals of India (Week – Nielsen Survey 2014) and won the prestigious award for Best Oncology Hospital in India at Healthcare Achievers’ Awards 2014.